• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Which brain hemorrhage patients have treatable underlying conditions

Bioengineer by Bioengineer
June 3, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study identifies patients more likely to have underlying lesions from brain-bleeds, a finding that could help doctors treat the condition more rapidly

PHILADELPHIA – When blood vessels in the brain rupture, or hemorrhage, and cause a stroke, large areas of the brain can be permanently damaged. Depending on the cause, some brain hemorrhages may hide underlying lesions that can be treated with surgery, embolization, radiation, or other treatments. Using MRI scans of patients diagnosed with intracerebral hemorrhage, clinical researchers at Jefferson have teased apart the groups most likely to have a treatable underlying condition.

The findings, published May 31st in the Journal of Neurosurgery, will help physicians determine which patients to send for immediate MRI and surgical treatment, and which should be treated with supportive care.

“Intracerebral hemorrhage can be highly disabling and every attempt should be made to treat underlying lesions to prevent rebleeding” says neurosurgeon and senior author Pascal Jabbour, MD Professor of Neurological Surgery and the Chief of the Division of Neurovascular and Endovascular Neurosurgery at the Sidney Kimmel Medical College at Thomas Jefferson University. “This study helps identify patients who have brain hemorrhages that are suspicious for underlying lesions and who should absolutely receive an MRI.”

Together with first author and Neurosurgery Chief Resident Nohra Chalouhi, MD, the research team reviewed the records of 400 patients diagnosed with intracerebral hemorrhage at Jefferson. The researchers found that as many as 12.5 percent of patients carried underlying brain lesions, and further characterized the demographics of those patients so that physicians could rapidly identify suspicious hemorrhages.

They found that there was a clear demarcation of the types of hemorrhages. When bleeding occurred deep in the basal ganglia, only 5 percent of patients had treatable underlying lesions on MRI. When the bleeds occurred in the brainstem or on the outer surface of the brain, on the other hand, the chance of finding a lesion rose dramatically to 15-30 percent. Patients were also remarkably more likely to harbor lesions if they didn’t also have hypertension.

The researchers also looked as age as a variable. “Patients over the age of 85 were very unlikely to have a treatable lesion,” says Dr. Chalouhi. “Whereas in a patient who was younger than 50, the likelihood of finding a structural lesion as a cause of the hemorrhage was 37 percent.”

The study found a large spectrum of lesions causing these hemorrhages. The most common of these were arteriovenous malformations, cavernous malformations, and brain tumors. Other causes included brain aneurysms, venous clots, and even brain abscesses or infections. These lesions were successfully treated at Jefferson Hospital for Neuroscience.

“For the first time, we have an algorithm for identifying patients with suspicious brain hemorrhages to undergo further testing and treatment,” says Dr. Jabbour.

###

The authors report no external funding for this study, and no conflicts of interest.

Article reference: Nohra Chalouhi, Nikolaos Mouchtouris, Somnath Das, Fadi Al Saiegh, Somnath Das, Ahmad Sweid, Adam E. Flanders, Robert M. Starke, Michael P. Baldassari, Stavropoula Tjoumakaris, Michael Reid Gooch, Syed O. Shah, David Hasan, Nabeel Herial, Robin D’Ambrosio, Robert Rosenwasser, Pascal Jabbour, “Analysis of the Utility of Early MRI/A in 400 patients with Spontaneous Intracerebral Hemorrhage,” Journal of Neurosurgery, DOI: 10.3171/2019.2.JNS183425, 2019.

Media Contact: Edyta Zielinska, 215-955-7359, [email protected].

Media Contact
Edyta Zielinska
[email protected]
http://dx.doi.org/10.3171/2019.2.JNS183425

Tags: Medicine/HealthneurobiologySurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Surface Engineering of SN38 Prodrug Nano-Assemblies: Contrasting Behaviors

September 22, 2025

TMolNet: Revolutionizing Molecular Property Prediction

September 21, 2025

NICU Families’ Stories Through Staff Perspectives

September 21, 2025

CT Scans in Kids: Cancer Risk Insights

September 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    68 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Efficient Deep-Blue CsPbBr3 LEDs Meet Rec.2020

Surface Engineering of SN38 Prodrug Nano-Assemblies: Contrasting Behaviors

New Strategies for Treating Capecitabine-Induced Hand-Foot Syndrome

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.